Artykuły w Czytelni Medycznej o SARS-CoV-2/Covid-19

Zastanawiasz się, jak wydać pracę doktorską, habilitacyjną lub monografię? Chcesz dokonać zmian w stylistyce i interpunkcji tekstu naukowego? Nic prostszego! Zaufaj Wydawnictwu Borgis – wydawcy renomowanych książek i czasopism medycznych. Zapewniamy przede wszystkim profesjonalne wsparcie w przygotowaniu pracy, opracowanie dokumentacji oraz druk pracy doktorskiej, magisterskiej, habilitacyjnej. Dzięki nam nie będziesz musiał zajmować się projektowaniem okładki oraz typografią książki.

Poniżej zamieściliśmy fragment artykułu. Informacja nt. dostępu do pełnej treści artykułu tutaj
© Borgis - New Medicine 2/2015, s. 59-61 | DOI: 10.5604/14270994.1169796
*Marcin Ciszewski1, Tomasz Czekaj1, Piotr Chojnacki2, Eligia M. Szewczyk1
New bacterial zoonotic pathogens
1Department of Pharmaceutical Microbiology and Microbiological Diagnostics, Medical University of Łódź, Poland
Head of Department: prof. Eligia M. Szewczyk, PhD
2Chair of Labour and Social Policy, Faculty of Economics and Sociology, University of Łódź, Poland
Head of Department: prof. Bogusława Urbaniak, PhD
Summary
The article presents the problem of new zoonotic bacterial pathogens posing a threat to humans. Currently, 11 pathogens responsible for causing human zoonotic diseases are being monitored by the European Union epidemiological authorities, 7 of which are bacteria: Salmonella spp., Campylobacter spp., Listeria monocytogenes, Mycobacterium bovis, Brucella spp., Escherichia coli VTEC/STEC and Coxiella burnetti. Nonetheless, many new emerging zoonotic bacteria, which are not currently monitored by ECDC might also pose a serious epidemiological problem in the foreseeable future: Streptococcus iniae, S. suis, S. dysgalactiae subsp. equisimilis and staphylococci: Staphylococcus intermedius and S. pseudintermedius. These species have just crossed the animal-human interspecies barrier. The mechanism of this phenomenon remains unknown. It is connected, however, with genetic variability and capability to survive in changing environment, which are the result of DNA rearrangement and horizontal gene transfer between bacterial cells. The recent substantial increase in the number of scientific publications on this subject testifies to the importance of the problem.
There are approximately 1400 pathogens which currently pose a threat to humans. Most of these pathogens are of zoonotic origin. Among them, there are the most dangerous pathogens, which broke the animal-human interspecies barrier in recent times. E.g. viruses like: HIV, H5N1 and H1H1 influenza, coronaviruses or Ebola have become a serious epidemiological problem during the last 50 years. The number of pathogenic viruses increases by approximately 25 every 10 years. Among bacteria, Helicobacter pylori, pathogenic serotypes of Escherichia coli (VTEC, EIEC, EPEC, EAggEC, DAEC, O104:H4) and Borrelia burgdorferi have emerged during last 50 years.
The primary reservoir of many species is the environment (e.g. Legionella pneumophila, Bacillus anthracis) but most of them (nearly 1000 species and varieties) originate from animal pathogens. Only about 3.5% of all etiological factors are exclusive to humans and nowadays do not have any animal or environmental reservoir. This group comprises e.g. Streptococcus pyogenes, Neisseria gonorrhoeae and Treponema pallidum (1). The notion „zoonoses” is usually used to describe infections that can be transmitted directly from animals to humans. Sometimes, when a pathogen gains the ability of human-to-human transmission, we forget about its animal origin. However, it is still able to infect its primary hosts and might be transported by them. Some zoonotic bacteria have over the years achieved the ability to cause epidemic diseases, like plague (caused by Yersinia pestis) and typhoid fever (caused by Rickettsia prowazekii). New zoonotic human RNA viruses are the most frequently noted, due to their spectacular epidemics, e.g. HIV (transmitted from apes), SARS (from civets), H5N1 influenza (from birds), H1N1 influenza (from pigs) and, last but not least, the most current – Ebola virus (from bats). According to Woolhouse and Gaunt (2), the danger of new zoonotic pathogens emergence (or new varieties of already known pathogens) is one of the biggest challenges of XXI century. Taylor et al. (1) proved that animal pathogens (bacteria and fungi) pose a three-fold higher danger of becoming new etiological factor of human diseases than bacteria and fungi of other origin.
The process of evolutionary changes in the transformation of an animal pathogen into a specialized pathogen of humans has already been described by Wolfe et al. (3). Five steps constituting this process are shown in figure 1. It also demonstrates the current location of the emerging pathogens described in the article. The bases of this evolutionary process usually remain unknown but it is connected with genetic variability and obtaining new features which allow bacteria to survive and spread in a new environment. This ability mainly results from horizontal gene transfer (HGT) and DNA rearrangements (4).
Fig. 1. Scheme presenting evolutionary transformation of zoonotic pathogens, including emerging zoonotic bacterial pathogens described in this article (3 – modified).
European Union epidemiological authorities collect data on zoonoses from all Member States. Their annual reports describe 11 most important zoonotic etiological factors, 7 of which are bacterial pathogens. European Union summary reports on zoonoses include following bacterial pathogens: Salmonella spp., Campylobacter spp., Escherichia coli O104:H4 (VTEC/STEC), Listeria monocytogenes, Mycobacterium bovis, Brucella spp. and Coxiella burnetti (5). These bacteria are well-known and described. However, the abovementioned list includes only some of zoonotic pathogens, selected arbitrarily by the epidemiological authorities, mainly connected with foodborne diseases. Over the last years many other animal pathogens have gained the ability to infect humans. Highlighting the presence of these new bacterial pathogens, as well as the fact that the EU list of monitored pathogens is no longer up-to-date, seems to be of vital importance.

Powyżej zamieściliśmy fragment artykułu, do którego możesz uzyskać pełny dostęp.

Płatny dostęp tylko do jednego, POWYŻSZEGO artykułu w Czytelni Medycznej
(uzyskany kod musi być wprowadzony na stronie artykułu, do którego został wykupiony)

Aby uzyskać płatny dostęp do pełnej treści powyższego artykułu wraz z piśmiennictwem , należy wprowadzić kod:

Kod (cena 19 zł za 7 dni dostępu) mogą Państwo uzyskać, przechodząc na tę stronę.
Wprowadzając kod, akceptują Państwo treść Regulaminu oraz potwierdzają zapoznanie się z nim.

 

 

Płatny dostęp do wszystkich zasobów Czytelni Medycznej

Aby uzyskać płatny dostęp do pełnej treści powyższego artykułu wraz z piśmiennictwem oraz WSZYSTKICH około 7000 artykułów Czytelni, należy wprowadzić kod:

Kod (cena 49 zł za 30 dni dostępu) mogą Państwo uzyskać, przechodząc na tę stronę.
Wprowadzając kod, akceptują Państwo treść Regulaminu oraz potwierdzają zapoznanie się z nim.

otrzymano: 2015-04-02
zaakceptowano do druku: 2015-04-28

Adres do korespondencji:
*Marcin Ciszewski
Department of Pharmaceutical Microbiology and Microbiological Diagnostics, Medical University of Łódź
137 Pomorska Str., 90-235 Łódź, Poland
tel.: +48 (22) 677-93-04
e-mail: marcin.ciszewski@umed.lodz.pl

New Medicine 2/2015
Strona internetowa czasopisma New Medicine